- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02585336
Changes in Sugar-sweetened Beverage Intake and Metabolic Health: Improving Metabolic Profile Very Effortlessly (IMPROVE)
Effects of Sugar-sweetened Beverage Consumption Changes on Metabolic Health: Improving Metabolic Profile Very Effortlessly (IMPROVE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sugar-sweetened beverages (SSBs) have been epidemiologically linked to serious health problems including heart disease, liver disease, and diabetes. This study will recruit frequent SSB drinkers who are employees at the University of California, San Francisco (UCSF) and measure markers of metabolic health on two occasions, 10 months apart. During this time, UCSF will cease selling SSBs at all campus and medical center locations. Additionally, at the first assessment half of participants will be randomly assigned to a brief intervention to help reduce SSB consumption, consisting of a 10-20 minute semi-structured interview designed to share health information about SSBs, elicit motivations to reduce consumption, and help set concrete plans to reduce consumption. We will be able to compare changes in metabolic health among those who do and do not reduce SSB consumption. This will make a unique contribution to the growing evidence regarding both the effects of SSB consumption on health and the modifiability of SSB-related health conditions.
Two key clarifications about the design of this study:
- The cessation of sugar-sweetened beverage sales is a pre-existing workplace initiative. This study is taking advantage of its initiation but it is not part of the study intervention.
- The primary predictor in this study is SSB consumption, not condition assignment. Although we will report on the efficacy of the brief intervention, the main goal of the study is to examine the correlational relationship between changes in SSB consumption and changes in health, whether the reduction is associated with the intervention or with other factors.
Planned analyses:
- For all outcomes other than sugar consumption and SSB consumption (see below), the primary analytic strategy will be to correlate changes in SSB consumption with changes in the outcome.
- We will additionally assess the efficacy of the university initiative and the brief counseling intervention using a linear mixed regression model estimating the effects of 1) time (pre to post), representing the effect of the university SSB initiative, and 2) assignment to the brief intervention interacting with time.
For both types of analysis, we will include demographic and job-related covariates based on fit criteria to guide model selection.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California, San Francisco
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Employed at UCSF
- Reports drinking an average of 60oz or more of sugar-sweetened beverages per week (approximately 8oz/day), over the past month.
Exclusion Criteria:
- Unwilling or medically advised not to fast in preparation for a fasting blood draw
- Reports vasovagal response (fainting) following blood draws or needle sticks in the past.
- Pregnant (health outcome measures from pre- to post-partum will not be comparable).
- Diagnosed with diabetes (type 1 or type 2)
- Not fluent in English
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Observation
|
|
|
Experimental: Brief intervention
|
An interviewer provides health information, elicits motivation to reduce SSB consumption, and helps participants make implementation plans.
Booster phone calls occur at 1 week after the intervention visit, and at 2 weeks and 24 weeks following the date on which SSBs sales ended at the participant's work location.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Homeostatic Model Assessment ratio (HOMA)
Time Frame: 10 month minus baseline
|
insulin sensitivity measure derived from fasting glucose and insulin
|
10 month minus baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Waist-hip circumference ratio
Time Frame: 10 month minus baseline
|
A measure of abdominal adiposity
|
10 month minus baseline
|
|
Consumption of sugar-sweetened beverages
Time Frame: 2 weeks post-SSB sales ban (1-3 months after initial visit) minus baseline
|
outcome for intervention efficacy analysis only
|
2 weeks post-SSB sales ban (1-3 months after initial visit) minus baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reward-based eating drive
Time Frame: 10 month minus baseline
|
self-report measure of hedonic drive in eating
|
10 month minus baseline
|
|
Consumption of sugar-sweetened beverages
Time Frame: 10 month minus baseline
|
In most analyses treated as a predictor, but used as an outcome when testing the efficacy of the intervention
|
10 month minus baseline
|
|
Total dietary sugar consumption
Time Frame: 10 month minus baseline
|
In most analyses treated as a predictor, but used as an outcome when testing the efficacy of the intervention
|
10 month minus baseline
|
|
Glycated hemoglobin (HbA1c)
Time Frame: 10 month minus baseline
|
Indicator of long-term glycemic control
|
10 month minus baseline
|
|
Fasting triglycerides
Time Frame: 10 month minus baseline
|
Marker of metabolic health and cardiovascular risk
|
10 month minus baseline
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Epel ES, Hartman A, Jacobs LM, Leung C, Cohn MA, Jensen L, Ishkanian L, Wojcicki J, Mason AE, Lustig RH, Stanhope KL, Schmidt LA. Association of a Workplace Sales Ban on Sugar-Sweetened Beverages With Employee Consumption of Sugar-Sweetened Beverages and Health. JAMA Intern Med. 2020 Jan 1;180(1):9-16. doi: 10.1001/jamainternmed.2019.4434.
- Wojcicki JM, Lustig RH, Jacobs LM, Mason AE, Hartman A, Leung C, Stanhope K, Lin J, Schmidt LA, Epel ES. Longer Leukocyte Telomere Length Predicts Stronger Response to a Workplace Sugar-Sweetened Beverage Sales Ban: An Exploratory Study. Curr Dev Nutr. 2021 May 26;5(7):nzab084. doi: 10.1093/cdn/nzab084. eCollection 2021 Jul.
- Mason AE, Schmidt L, Ishkanian L, Jacobs LM, Leung C, Jensen L, Cohn MA, Schleicher S, Hartman AR, Wojcicki JM, Lustig RH, Epel ES. A Brief Motivational Intervention Differentially Reduces Sugar-sweetened Beverage (SSB) Consumption. Ann Behav Med. 2021 Oct 27;55(11):1116-1129. doi: 10.1093/abm/kaaa123.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 15-16880
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Health
-
UMC UtrechtCompletedCardiovascular Health | Metabolic Health | Pulmonary HealthNetherlands
-
One Bio Inc.People Science, Inc.CompletedMetabolic Health | Digestive HealthUnited States
-
University of AberdeenMedical Research Council; University of LiverpoolCompletedGut Health | Metabolic HealthUnited Kingdom
-
Instituto Politécnico da GuardaCompleted
-
AdventHealth Translational Research InstituteCompletedMetabolic HealthUnited States
-
Daily NouriRecruiting
-
ViomeRecruitingMetabolic HealthUnited States
-
Nature's Sunshine Products, Inc.Completed
-
University of NottinghamCompletedMetabolic HealthUnited Kingdom
-
Aga Khan UniversityBill and Melinda Gates Foundation; University of MinnesotaCompleted
Clinical Trials on Brief intervention
-
i4HealthTerminated
-
University of Texas at AustinNational Institute on Drug Abuse (NIDA)Completed
-
New York State Psychiatric InstituteCompletedDepression | Mental Health Disorder | Adolescent Behavior | Stigma, SocialUnited States
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedDrug Abuse | HIV Risk BehaviorUnited States
-
Wayne State UniversityNational Institute on Drug Abuse (NIDA)Completed
-
Friends Research Institute, Inc.National Institute on Drug Abuse (NIDA)CompletedRisk Behavior | Marijuana Use | Alcohol Consumption | Unsafe Sex
-
New York State Psychiatric InstituteCompletedDepression | Mental Health Disorder | Stigma, SocialUnited States
-
University of MichiganNational Institute on Drug Abuse (NIDA)CompletedDrug Use | Sex BehaviorUnited States
-
University of Dublin, Trinity CollegeCompletedSpondylitis, AnkylosingIreland
-
The Miriam HospitalNational Institute of Mental Health (NIMH); University of Rochester; Syracuse...CompletedHIV Infections | Sexually Transmitted DiseasesUnited States